Funded out Association’s general revenues and does not use industry support. Funded out Association’s general revenues and does not use industry support

Successful practices prioritize providing a high quality of care. Changes that have been shown to increase quality of care include:

• Successful practices prioritize providing a high quality of care. Changes that have been shown to increase quality of care include:

• Removing financial barriers and reducing patient out-of-pocket costs
• Identifying community resources and public policy that supports healthy lifestyles
• Coordinated primary care, e.g., through Patient-Centered Medical Home
• Changes to reimbursement structure

Key Recommendation

• Key Recommendation

• Providers should assess social context, including potential food insecurity, housing stability, and financial barriers, and apply that information to treatment decisions. A

Ethnic/Cultural/Sex Differences

• Ethnic/Cultural/Sex Differences

• Access to Health Care

• Lack of Health Insurance

• Food Insecurity

• Language Barriers

• Homelessness

Key Recommendations

• Key Recommendations

• Patients should be referred to local community resources when available. B

• Patients should be provided with self-management support from lay health coaches, navigators, or community health workers when available. A

Classification

• Classification

• Diagnostic Tests for Diabetes

• Prediabetes

• Type 1 Diabetes

• Type 2 Diabetes

• Gestational Diabetes

• Monogenic Diabetes Syndromes

• Cystic Fibrosis-Related Diabetes

Type 1 diabetes

• Type 1 diabetes

• β-cell destruction

• Type 2 diabetes

• Progressive insulin secretory defect

• Gestational Diabetes Mellitus (GDM)

• Other specific types of diabetes

• Monogenic diabetes syndromes
• Diseases of the exocrine pancreas, e.g., cystic fibrosis
• Drug- or chemical-induced diabetes

Blood glucose rather than A1C should be used to dx type 1 diabetes in symptomatic individuals. E

• Blood glucose rather than A1C should be used to dx type 1 diabetes in symptomatic individuals. E

• Screening for type 1 diabetes with an antibody panel is recommended only in the setting of a clinical research study or in a first-degree family members of a proband with type 1 diabetes. B

• www.DiabetesTrialNet.org

Screening for prediabetes with an informal assessment of risk factors or validated tools should be considered in asymptomatic adults. B

• Screening for prediabetes with an informal assessment of risk factors or validated tools should be considered in asymptomatic adults. B

• Testing should begin at age 45 for all people. B

• Consider testing for prediabetes in asymptomatic adults of any age w/ BMI ≥25 kg/m2 or ≥23 kg/m2 (in Asian Americans) who have 1 or more add’l risk factors for diabetes. B

• If tests are normal, repeat at a minimum of 3-year intervals. C

FPG, 2-h PG after 75-g OGTT, and A1C, are equally appropriate for prediabetes testing. B

• FPG, 2-h PG after 75-g OGTT, and A1C, are equally appropriate for prediabetes testing. B

• In patients with prediabetes, identify and, if appropriate, treat other CVD risk factors. B

• Consider prediabetes testing in overweight/obese children and adolescents with 2 or more add’l diabetes risk factors. E

Screening for type 2 diabetes with an informal assessment of risk factors or validated tools should be considered in asymptomatic adults. B

• Screening for type 2 diabetes with an informal assessment of risk factors or validated tools should be considered in asymptomatic adults. B

• Consider testing in asymptomatic adults of any age with BMI ≥25 kg/m2 or ≥23 kg/m2 in Asian Americans who have 1 or more add’l dm risk factors. B

• For all patients, testing should begin at age 45 years. B

• If tests are normal, repeat testing carried out at a minimum of 3-year intervals is reasonable. C

FPG, 2-h PG after 75-g OGTT, and the A1C are equally appropriate. B

• FPG, 2-h PG after 75-g OGTT, and the A1C are equally appropriate. B

• In patients with diabetes, identify and, if appropriate, treat other CVD risk factors. B

• Consider testing for T2DM in overweight/obese children and adolescents with 2 or more add’l diabetes risk factors. E

Overweight plus any 2 :

• Overweight plus any 2 :

• Family history of type 2 diabetes in 1st or 2nd degree relative
• Race/ethnicity
• Signs of insulin resistance or conditions associated with insulin resistance
• Maternal history of diabetes or GDM
•